logo
#

Latest news with #MotoAmerica

MotoAmerica Superbike Racing moves to Peacock with Round 3 at Road America
MotoAmerica Superbike Racing moves to Peacock with Round 3 at Road America

NBC Sports

time3 days ago

  • Automotive
  • NBC Sports

MotoAmerica Superbike Racing moves to Peacock with Round 3 at Road America

Peacock and the NBC Sports Now Channel will stream the final seven rounds of MotoAmerica's Superbike Series, beginning with two races at Road America in Elkhart Lake, Wisconsin, streamed on May 31 and June 1. 'MotoAmerica is a great addition to Peacock's expansive and growing portfolio of motorsports properties,' Matt Grassie, Director, Programming & Rights Management, NBC Sports, said in a news release. 'The premier motorcycle road racing series in the U.S., live-streaming MotoAmerica on Peacock will provide fans nationwide with exhilarating, fast-paced competition.' Most Superbike race weekends feature two races, one on Saturday and another on Sunday. The exceptions are Round 5 at Laguna Seca in Monterey, California, and the season finale at New Jersey Motorsports Park in Millville, New Jersey. These rounds feature three races, with two races scheduled as part of their Sunday program. Cameron Beaubier leads the field into Road America after winning three of the first four races. He swept the weekend at Road Atlanta in early May and split the first round with Jake Gagne at Barber Motorsports Park in Birmingham, Alabama, in April. With three victories, Beaubier holds a 23-point advantage over Gagne, but with 16 races remaining and a maximum of 25 points earned for each victory, the championship is still up for grabs. 'We're thrilled to bring MotoAmerica to an even broader audience,' said MotoAmerica's COO Chuck Aksland. 'Peacock, with nearly 100 million monthly active users, and NBC Sports NOW offer a tremendous platform to showcase our racing series alongside world-class sports. Being part of such a dynamic and respected streaming service not only elevates our visibility but also makes it easier than ever for fans to watch and follow MotoAmerica Superbikes. We're excited to kick off our partnership with NBC Sports at the next round in Wisconsin.' 2025 Superbike Series April 4 - 6: Barber Motorsports Park, Birmingham, Alabama (Winners: Cameron Beaubier, Jake Gagne) May 2 - 4: Road Atlanta, Braselton, Georgia (Winner: Cameron Beaubier) May 30 - June 1: Road America, Elkhart Lake, Wisconsin June 27 - 29: Ridge Motorsports Park, Shelton, Washington July 11 - 13: Laguna Seca, Monterey, California August 1 - 3: Virginia International Raceway, Alton, Virginia August 15 - 17: Mid-Ohio Sports Car Course, Lexington, Ohio September 12 - 14: Circuit of the Americas, Austin, Texas September 26 - 28: New Jersey Motorsports Park, Millville, New Jersey NBC Sports

MOTOAMERICA SUPERBIKE RACES TO STREAM LIVE ON PEACOCK AND THE NBC SPORTS NOW FAST CHANNEL THIS SEASON
MOTOAMERICA SUPERBIKE RACES TO STREAM LIVE ON PEACOCK AND THE NBC SPORTS NOW FAST CHANNEL THIS SEASON

NBC Sports

time3 days ago

  • Automotive
  • NBC Sports

MOTOAMERICA SUPERBIKE RACES TO STREAM LIVE ON PEACOCK AND THE NBC SPORTS NOW FAST CHANNEL THIS SEASON

Peacock Will Stream MotoAmerica's Premier Superbike Class, Beginning with Road America's Two Races IRVINE, CA (May 29, 2025) – MotoAmerica, North America's premier motorcycle road racing series, is pleased to announce that beginning with the next round of its championship at Road America in Elkhart Lake, Wisconsin, May 30-June 1, MotoAmerica's premier Superbike class will stream live on Peacock, NBCUniversal's streaming service, and the NBC Sports NOW Fast Channel. Fans will be able to stream both Superbike races for the remainder of the 2025 season on Peacock and NBC Sports NOW, with expanded access to on-demand and broadcast replays through NBC Sports NOW. MotoAmerica Superbike racing will bring the remaining 16 Superbike races to Peacock subscribers this year, joining other live sports on the platform, including the Olympics and Paralympics, Sunday Night Football, Big Ten Football and Basketball, Notre Dame Football, Premier League, NASCAR, golf, the NBA beginning in 2025-26, the WNBA beginning in 2026, and much more. 'We're thrilled to bring MotoAmerica to an even broader audience,' said MotoAmerica's COO Chuck Aksland. 'Peacock, with nearly 100 million monthly active users, and NBC Sports NOW offer a tremendous platform to showcase our racing series alongside world-class sports. Being part of such a dynamic and respected streaming service not only elevates our visibility but also makes it easier than ever for fans to watch and follow MotoAmerica Superbikes. We're excited to kick off our partnership with NBC Sports at the next round in Wisconsin.' 'MotoAmerica is a great addition to Peacock's expansive and growing portfolio of motorsports properties,' said Matt Grassie, Director, Programming & Rights Management, NBC Sports. 'The premier motorcycle road racing series in the U.S., livestreaming MotoAmerca on Peacock will provide fans nationwide with exhilarating, fast-paced competition.' 2025 NBC SPORTS MOTOAMERICA SCHEDULE LIVE ON PEACOCK ABOUT PEACOCK Peacock's expansive sports programming features live coverage including Sunday Night Football, Olympic and Paralympic Games, Big Ten Football and Basketball, Notre Dame Football, Premier League, NASCAR, golf, the NBA beginning in 2025-26, the WNBA beginning in 2026, La Copa Mundial de la FIFA 2026, BIG EAST basketball, and much more. Peacock also offers daily sports programming on the NBC Sports channel.

MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races

Yahoo

time01-05-2025

  • Health
  • Yahoo

MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races

The test, run on Abbott's portable i-STAT® Alinity® hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concussion, producing lab-quality results in 15 minutes The test will be used by healthcare professionals in the medical facilities at all MotoAmerica races in 2025 ABBOTT PARK, Ill., and IRVINE, Calif., May 1, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare company, and MotoAmerica, the premier motorcycle road racing series in North America, announced today that MotoAmerica is the first professional sports organization worldwide to use Abbott's groundbreaking blood test to help assess suspected concussions for riders in the on-site medical facilities at all races. Abbott's test, the i-STAT TBI test cartridge, is used to evaluate patients 18 years of age and older who present with suspected mild traumatic brain injury (mTBI). It provides results in 15 minutes and may be used up to 24 hours after injury to help determine the need for a CT scan of the head. In 2024, Abbott's i-STAT TBI test received clearance from the U.S. Food and Drug Administration (FDA) to be used with whole blood, allowing doctors to quickly assess patients with suspected mTBI on the handheld i-STAT Alinity analyzer at the patient's side. "This is the first ever objective test that physicians have had at the point-of-care to assist in the assessment of concussions – it changes the game," said Carl Price, M.D., chief medical officer for MotoAmerica. "If a crash or fall does happen, the ability to quickly and objectively determine whether or not a rider needs a CT scan or additional evaluation, right there on-site, provides us—and our riders—with peace of mind." The i-STAT TBI test cartridge will be available in on-site medical facilities for all MotoAmerica races across the U.S. during the 2025 season, beginning with the race at Michelin Raceway Road in Atlanta, Ga. (May 2-4). "As both a neurologist and licensed physician, I know firsthand the limitations of relying on a subjective tool like the Glasgow Coma Scale in the assessment of brain injury," said Beth McQuiston, M.D., medical director in Abbott's diagnostics business. "The ability to objectively assess the need for a head CT scan following potential brain injury right at the point of care, whether that be at a hospital bedside or an on-site medical facility at a sporting event, means quick assessment and a quick path to the right treatment." At MotoAmerica, riders wear comprehensive protection, including airbag-equipped suits that inflate on impact, helmets tested for multiple impact forces, and full-body armor. The tracks also feature air fence barriers and a dedicated medical safety car. In the event of a crash or fall, immediate on-site assessment adds an extra layer of safety to determine if a rider requires a CT scan or further evaluation. "The standard of competition and performance in MotoAmerica continues to increase," said Chuck Aksland, chief operating officer, MotoAmerica. "Between the riders, the motorcycles, their gear, and now accessibility to the most innovative medical equipment, we continue to push our standards and practices to better protect our racers. Our use of Abbott's rapid blood test for concussion assessment furthers this commitment and will help us evaluate medical needs quickly and on location." According to the National Institutes of Health (NIH), traumatic brain injury from accidents or sports is a leading cause of death and disability in the United States. The Centers for Disease Control and Prevention (CDC) estimates 2.5 million people visit the emergency department for TBIs every year. How the test worksThe i-STAT TBI test cartridge with the i-STAT Alinity System requires a small venous blood sample – just a few drops applied to the test cartridge. The cartridge is then inserted into the portable i-STAT Alinity instrument. The test measures two brain-specific biomarkers that are released into the blood stream when there is a significant brain injury. If neither of these biomarkers measured are above an established cutoff, a significant injury has likely not occurred, and a CT scan can likely be avoided. Testing for these two biomarkers – ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) – following an injury can provide essential and objective information about a patient's condition and can help healthcare providers decide an appropriate treatment plan. The test was developed by Abbott, with support from the U.S. Army Medical Research and Development Command's (USAMRDC) U.S. Army Medical Materiel Development Activity (USAMMDA) and in collaboration with Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI). The ability to use whole blood to help assess patients with suspected mTBI is an important step in Abbott's vision to make its tests available in all settings where people seek care for head injuries. Today, the test is available to be used by hospitals, clinics, and any athletic organization with trained medical staff on-site and the ability to run moderately complex testing. Research and planning are ongoing to determine the feasibility of using these biomarkers similarly in teens and children. About MotoAmerica:MotoAmerica is officially sanctioned by the American Motorcyclist Association (AMA) and the Fédération Internationale de Motocyclisme (FIM), and it features nine classes of motorcycle road racing: Superbike, Supersport, King of the Baggers, Talent Cup, Super Hooligan, Stock 1000, Twins Cup, Build. Train. Race. and Mini Cup. About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Connect with us at and on LinkedIn, Facebook, Instagram, X and Youtube. The i-STAT TBI test cartridge was developed with support by the U.S. Department of Defense U.S. Army Medical Research and Development Command's (USAMRDC) U.S. Army Medical Materiel Development Activity (USAMMDA). The USAMRDC has been dedicated to developing a solution for the objective detection and evaluation of TBI for more than two decades and has played a critical role in developing the TBI test on Abbott's i-STAT Alinity platform. (Reference to USAMRDC and USAMMDA does not imply or constitute endorsement by these organizations or by the Department of Defense or the U.S. Army.) The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) research team was the first to demonstrate how this TBI blood test can be used for the benefit of TBI patients in clinical care. View original content: SOURCE Abbott Sign in to access your portfolio

Evolution Optiks Technology to Aid MotoAmerica in Concussion Diagnostics
Evolution Optiks Technology to Aid MotoAmerica in Concussion Diagnostics

Associated Press

time30-01-2025

  • Automotive
  • Associated Press

Evolution Optiks Technology to Aid MotoAmerica in Concussion Diagnostics

CHRIST CHURCH, Barbados, Jan. 30, 2025 /PRNewswire/ -- Each time motorcycle racers go out on track, they are twisting the tiger's tail. They live for the thrill of speed and pushing themselves to the extreme. The danger is real and that's why motorcycle racing is one of the most exciting spectator sports. However, where there is risk, there is injury which makes rider safety a big topic in motorcycle racing. Since its inception in 2015, MotoAmerica, the premier US pro motorcycle road racing series, has been a forerunner in eliminating or reducing injury. Their riders are clad in some of the world's best safety gear and their bikes are equipped with a whole range of features designed to protect the racers. 'We care about the well-being of our riders and make every effort to keep them as safe as possible by providing the best available gear and equipment and using state-of-the-art technology in injury assessment', says MotoAmerica COO Chuck Aksland. Since one of the most common injuries in motorcycle racing is concussion/mTBI (mild traumatic brain injury), MotoAmerica introduced a concussion protocol early on and has continuously adopted novel and more advanced tools and screening systems as they became available. Renowned and multi-published Concussion and Vestibular Specialist Jim Buskirk, Assistant Professor at Chicago's Rosalind Franklin University, provides the medical expertise, in collaboration with MotoAmerica's Chief Medical Officer, Dr. Carl Price. Jim's primary research interest is the recovery of function following concussion/mTBI in sports and he works with various motorsports organizations, professional sports teams as well as amateur youth sports associations. He says: 'As a researcher, I am always on the lookout for new technologies to improve the assessment and treatment of mTBI. So when Dr. Steve Olvey, my co-consultant at IndyCar and Chief Medical Advisor for Evolution Optiks, introduced me to DeCon, my interest was piqued. I had the chance to use the device for testing and data collection and it has so much potential that this season, I'm planning on a full IRB study with DeCon for MotoAmerica.' Dr. Carl Price adds: 'We are fortunate to have an expert like Jim Buskirk on our team to help us manage concussion in our sport. The DeCon device, together with clinical findings, may become an integral part of our concussion management program. We are also excited to add new peripheral blood biomarkers to this mix and feel that the combination will advance the science, but more importantly, the care of our riders.' DeCon is the flagship product of the NeuroDynamiks ™ brand of Evolution Optiks - the leading name in light field technology solutions. The portable head-mounted device uses proprietary technology to track and analyze involuntary movements of the eye in response to visual stimuli and positional changes. DeCon can perform dozens of established and new neurological tests, the results of which are simultaneously recorded on the device and, if required, can be made available remotely for interpretation by a qualified medical practitioner. Its compact and relatively lightweight design makes it ideal for sideline use, allowing for rapid diagnosis and treatment decision-making. With added AI-based optimizations, the potential for the DeCon device expands tenfold into a broad space of medical conditions and performance training, by analyzing objective data collected from its onboard cameras and sensors and cross-checking against large data sets of previously diagnosed cases. AI-based analysis of individual patient factors, crash characteristics, and correlation with other diagnostic methodologies will enable personalized treatment plans, accurate predictions of recovery times, and early identification of potential complications.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store